Ruti Aga banned for six years: a forged knee-treatment prescription turned a two-year sanction into six

Ethiopian marathon runner Ruti Aga has been banned for six years by the Athletics Integrity Unit (AIU). The sanction is built from two separate violations — two years for the presence of a prohibited substance in her sample, and four years for submitting a fabricated document and giving misleading statements during the investigation. According to the AIU statement issued on Thursday, the ban is counted from 10 September, the same date she was provisionally suspended.

On the surface this looks like one more doping case. But the real story here is not the drug — it is the prescription that was produced: one bearing the name of a clinic that did not exist, signed by a 'doctor' who was a family member with no medical registration. That detail is what turns this into a case study in sports jurisprudence. The injury was real. The treatment was legitimate. The legal defence was open. And then a forged piece of paper destroyed all of it.

The arithmetic of the sanction

According to the AIU, Aga's sample was collected after a half marathon in China in March, which she won. Her time in that race is not disclosed in the statement, nor is the depth of the field. From a performance standpoint, therefore, the report contains almost nothing concrete — only that she won and that her test came back positive. Any conclusion about that performance would be fabrication. What matters is not the result but the disqualification.

The structure of the ban is worth understanding. The standard sanction for presence of a prohibited substance is two years, particularly where the substance falls in the 'Specified Substance' category and intent has not been established. On top of that sits a separate four-year sanction for tampering. Two and four make six. That arithmetic tells us the panel did not find intent on the substance charge but held her fully culpable on the document — and therefore rejected the 'no significant fault' mitigation that would otherwise have reduced the presence sanction.

Backdating the ban to the provisional suspension date is technically in the athlete's favour, but the practical benefit is close to zero. The six-year clock starts on 10 September, and at 32 years of age it will keep her out of the sport until roughly 38.

What the drug actually was: a necessary technical correction

There is a significant technical error in the media coverage of this case. Methylprednisolone has been widely described as a 'prohibited steroid' and as something WADA classifies as performance-enhancing. That is imprecise.

Methylprednisolone is a glucocorticoid, not an anabolic steroid. It sits in class S9 of the WADA Prohibited List, and under the current List S9 glucocorticoids are prohibited in-competition only — and only by injection, oral or rectal route. A therapeutic knee injection administered out-of-competition is entirely legal; it becomes a violation only if residues are present in a sample taken in-competition. In road racing the testing window opens at 23:59 the day before the race, so an injection given days earlier can still be caught.

That distinction matters enormously, because it moves the entire case away from 'steroid use' and onto route of administration and timing relative to the competition. And that is precisely where Aga had a legitimate defence available.

The knee injury and the prescription

According to the AIU statement, Aga cited a knee injury and said the substance was administered as treatment. Intra-articular or peri-articular glucocorticoid injection for knee synovitis is standard sports-medicine practice in distance runners. The injury explanation is therefore technically plausible.

But that very plausibility is what made the forgery fatal. The prescription produced during the investigation came from a clinic that did not exist. The person who issued it was a family member, not a registered medical practitioner. Questioned about it, that person claimed to have used 'an old prescription pad from a former workplace' — a claim the clinic explicitly disowned. Three independent verification failures at once.

The result: a case in which genuine medical records could have earned mitigation became a case carrying four additional years. This is the near-paradox of the affair — forged documentation is itself circumstantial evidence of an intent to conceal, yet the panel did not escalate the underlying presence sanction on the basis of it.

An individual error, a systemic crisis

It is easy to read this as one runner's mistake, but the institutional message is more serious. Nowhere does the AIU statement mention a credentialed team physician. There is no sign of any attempt to obtain a Therapeutic Use Exemption. Nor is there any indication that anyone explained the required washout interval before competition. Where the medical ecosystem is informal, the remedy for missing documentation is not to manufacture documentation — it is to obtain valid documentation.

This problem is not isolated in East African road-running entourages. Agents, training camps and clinics in the same regions together form a network in which racing through injury is economically rational — particularly in the marathon, where appearance fees and sponsor dependency are high and careers are short. Chronic knee pathology is a known load-bearing failure mode in marathoners, and glucocorticoids are the cheapest, most readily available way to suppress the pain. In that sense the forged document is downstream of a governance gap, not its cause.

There is a further detail worth noting: the tampering sanction arises not from a document alone but from an interview — that is, from statements made under questioning. Language and translation conditions in AIU interviews with East African athletes have been a recurring point of contention. It is a fair question to raise, though in this case the underlying falsity of the document is so clear that the translation argument does not get very far.

Career arithmetic: 32 to 38

Aga is known in elite marathon running as a 2:18 to 2:20 class performer. Her biggest result is the 2026 Tokyo Marathon title, and she has three second-place finishes at World Marathon Majors. That is the record of a genuinely elite career, and this case does not erase it automatically — at least not until earlier use is established. The violation is anchored to the March race; the 2026 title is not automatically annulled. The statement, however, does not specify the scope of disqualification. Standard practice is that the result and prize money from the competition where the sample was collected are voided, but without official confirmation that should not be treated as settled fact.

A six-year ban removes her entirely from the 2028 Olympic cycle. At 32, that is effectively the end of a career, because the depth of Ethiopian women's marathoning makes it almost inconceivable that a 38-year-old returning with a doping record would be selected again. On paper the ban is six years. In practice it is a lifetime one.

China's label races and shifting scrutiny

A less discussed aspect of this case is where the sample was taken. The March half marathon in China — presumably a World Athletics Label road race with an elite women's field and in-competition testing — belongs to the tier that has long served as a lucrative, low-risk income stream for East African marathoners between Majors. Large appearance-fee budgets, deep elite fields and the AIU's presence are now colliding in the same races.

So this case is both individual and structural. Individual in that a 32-year-old athlete ended her own career with her own hands; structural in that the AIU's enforcement focus is shifting from detection to document verification. Cases in which an initial violation is compounded by a fabricated or altered explanation are no longer isolated events.

The appeal route, and its limits

Procedurally, Aga can appeal to the Court of Arbitration for Sport, typically within about 21 days of the reasoned decision. But the tampering finding is document-based, and such findings are hard to overturn. The substance sanction can be argued; the falsity of the document cannot really be. The document issue also carries a criminal dimension that falls outside the AIU's jurisdiction and could be referred to national authorities — something the statement does not address.

An inconvenient fact

One thing about this case is uncomfortable: a six-year ban has been imposed for a substance with no proven endurance benefit. Reading anabolic steroids and glucocorticoids as if they belong in the same box distorts the picture — and that distortion was visible in the media coverage. On the other hand, four years for documentary tampering is entirely standard, so it is not easy to argue that the sanction is disproportionate.

What can be said with confidence is this: had Aga had a credentialed team physician, a valid prescription, and clear guidance on when to stop the medication before competition, there would be no case today. The six years are not for the drug. They are for the piece of paper that was created to hide it.